Skip to content

Tetragon Partners GP Ltd

Follow

13F filer, CIK 1515070, GRAND CAYMAN, Cayman Islands

Tetragon Partners GP Ltd reported $765,964,261 across 37 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 80.67% of the portfolio.

Accepted , ingested 13F-HR 0000919574-26-008018

Period
2026-09-30
Reported value
$766M
Holdings
37
Top 10 weight
80.67%
New
6
Sold out
8

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PATHadded+1,550,000$19.9M
SLNadded+1,671,795$18.3M
PHVSadded+542,620$17.2M
IONSadded+343,757$15.3M
ARWRadded+133,556$8.74M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AMLXexited-297,926-$5.35M
ACADexited-167,875-$4.25M
CUEexited-93,819-$2.96M
ANNXreduced-586,507-$2.48M
RLAYreduced-123,076-$2.22M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0000919574-26-008018, largest first. % of portfolio is the value over $757,501,822, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PATHUIPATH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,950,000 shares; 2025Q1: 8,950,000 shares; 2025Q2: 13,722,244 shares; 2025Q3: 16,950,000 shares; 2025Q4: 17,450,000 shares; 2026Q1: 25,207,628 shares; 2026Q2: 30,950,000 shares; 2026Q3: 32,500,000 shares 32,500,000$417M55.09%+1,550,000Timeline
KGEIKOLIBRI GLOBAL ENERGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,070,568 shares; 2025Q1: 7,070,568 shares; 2025Q2: 7,068,857 shares; 2025Q3: 7,070,568 shares; 2025Q4: 6,934,504 shares; 2026Q1: 6,834,504 shares; 2026Q2: 6,834,504 shares; 2026Q3: 6,834,504 shares 6,834,504$42.3M5.58%0Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 365,369 shares; 2026Q1: 630,161 shares; 2026Q2: 764,256 shares; 2026Q3: 2,436,051 shares 2,436,051$26.6M3.51%+1,671,795Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 126,995 shares; 2025Q2: 188,100 shares; 2025Q3: 194,612 shares; 2025Q4: 194,612 shares; 2026Q1: 221,611 shares; 2026Q2: 295,627 shares; 2026Q3: 838,247 shares 838,247$26.6M3.51%+542,620Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 41,764 shares; 2026Q2: 97,173 shares; 2026Q3: 440,930 shares 440,930$19.7M2.6%+343,757Timeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,250,000 shares; 2025Q1: 8,600,000 shares; 2025Q2: 9,500,000 shares; 2025Q3: 9,500,000 shares; 2025Q4: 9,500,000 shares; 2026Q1: 9,500,000 shares; 2026Q2: 9,500,000 shares; 2026Q3: 9,500,000 shares 9,500,000$18.4M2.43%0Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 81,841 shares; 2025Q4: 96,935 shares; 2026Q1: 127,198 shares; 2026Q2: 130,484 shares; 2026Q3: 264,040 shares 264,040$17.3M2.28%+133,556Timeline
LYFTLYFT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,000,000 shares; 2025Q1: 1,000,000 shares; 2025Q2: 1,000,000 shares; 2025Q3: 1,000,000 shares; 2025Q4: 1,000,000 shares; 2026Q1: 1,000,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000$15M1.98%0Timeline
WKWORKIVA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 150,000 shares; 2025Q3: 150,000 shares; 2025Q4: 150,000 shares; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares; 2026Q3: 225,000 shares 225,000$15M1.98%-25,000Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 177,840 shares; 2025Q4: 143,327 shares; 2026Q1: 145,480 shares; 2026Q2: 203,543 shares; 2026Q3: 220,647 shares 220,647$12.9M1.71%+17,104Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 199,994 shares; 2026Q2: 286,990 shares; 2026Q3: 310,892 shares 310,892$11.8M1.56%+23,902Timeline
CXMSPRINKLR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,200,000 shares; 2025Q1: 2,200,000 shares; 2025Q2: 2,200,000 shares; 2025Q3: 2,200,000 shares; 2025Q4: 2,200,000 shares; 2026Q1: 2,200,000 shares; 2026Q2: 2,200,000 shares; 2026Q3: 2,200,000 shares 2,200,000$10.9M1.44%0Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 192,000 shares; 2025Q1: 261,000 shares; 2025Q2: 316,150 shares; 2025Q3: 303,600 shares; 2025Q4: 243,800 shares; 2026Q1: 312,316 shares; 2026Q2: 290,441 shares; 2026Q3: 295,941 shares 295,941$9.59M1.27%+5,500Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 131,167 shares; 2025Q2: 147,817 shares; 2025Q3: 188,379 shares; 2025Q4: 166,187 shares; 2026Q1: 218,507 shares; 2026Q2: 255,934 shares; 2026Q3: 275,219 shares 275,219$9.3M1.23%+19,285Timeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 82,824 shares; 2026Q1: 119,340 shares; 2026Q2: 201,036 shares; 2026Q3: 226,677 shares 226,677$8.9M1.17%+25,641Timeline
ALKTALKAMI TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 600,284 shares; 2026Q3: 650,000 shares 650,000$8.9M1.17%+49,716Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 15,632 shares; 2025Q3: 89,612 shares; 2025Q4: 141,172 shares; 2026Q1: 159,791 shares; 2026Q2: 189,979 shares; 2026Q3: 206,778 shares 206,778$8.38M1.11%+16,799Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 138,375 shares; 2025Q3: 223,181 shares; 2025Q4: 247,997 shares; 2026Q1: 258,132 shares; 2026Q2: 356,657 shares; 2026Q3: 511,280 shares 511,280$8.24M1.09%+154,623Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 619,000 shares; 2025Q2: 699,000 shares; 2025Q3: 223,123 shares; 2025Q4: not reported; 2026Q1: 181,543 shares; 2026Q2: 570,311 shares; 2026Q3: 447,235 shares 447,235$8.07M1.07%-123,076Timeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 162,018 shares; 2026Q1: 164,839 shares; 2026Q2: 205,579 shares; 2026Q3: 215,529 shares 215,529$7.17M0.95%+9,950Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 64,110 shares; 2026Q3: 87,421 shares 87,421$6.95M0.92%+23,311Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 47,014 shares 47,014$6.67M0.88%newTimeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,870 shares; 2025Q4: 11,814 shares; 2026Q1: 19,668 shares; 2026Q2: 19,668 shares; 2026Q3: 19,668 shares 19,668$6.54M0.86%0Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 41,250 shares; 2025Q1: 33,806 shares; 2025Q2: 41,531 shares; 2025Q3: 46,456 shares; 2025Q4: 26,934 shares; 2026Q1: 20,059 shares; 2026Q2: not reported; 2026Q3: 35,000 shares 35,000$6.45M0.85%newTimeline
WBDWARNER BROS DISCOVERY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 923,725 shares; 2026Q2: 250,000 shares; 2026Q3: 200,000 shares 200,000$6.19M0.82%-50,000Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 69,287 shares; 2026Q1: 103,037 shares; 2026Q2: 86,996 shares; 2026Q3: 101,645 shares 101,645$6.15M0.81%+14,649Timeline
UBERUBER TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 71,428 shares 71,428$4.89M0.65%newTimeline
SNOWSNOWFLAKE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares; 2026Q3: 10,000 shares 10,000$3.4M0.45%0Timeline
ANTXAN2 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 603,424 shares 603,424$3.21M0.42%newTimeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,400,000 shares; 2025Q1: 2,650,000 shares; 2025Q2: 2,810,000 shares; 2025Q3: 2,112,455 shares; 2025Q4: 2,032,455 shares; 2026Q1: 1,292,455 shares; 2026Q2: 1,242,455 shares; 2026Q3: 655,948 shares 655,948$2.77M0.37%-586,507Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 56,052 shares; 2026Q3: 56,052 shares 56,052$669K0.09%0Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 187,500 shares; 2025Q2: 228,832 shares; 2025Q3: 243,728 shares; 2025Q4: not reported; 2026Q1: 37,588 shares; 2026Q2: 46,516 shares; 2026Q3: 26,798 shares 26,798$624K0.08%-19,718Timeline
SLGLSOL-GEL TECHNOLOGIES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 8,307 shares 8,307$617K0.08%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SLNSILENCE THERAPEUTICS PLC ADScall500,000$5.46M+200,000
AGIOAGIOS PHARMACEUTICALS INC COMcall50,000$1.66M0
GLUEMONTE ROSA THERAPEUTICS INC COMcall100,000$1.19Mnew
TENXTENAX THERAPEUTICS INC COM NEWcall75,100$142K0

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AXSMAXSOME THERAPEUTICS INC.35,000$8.57Mcall
AMLXAMYLYX PHARMACEUTICALS INC297,926$5.35Mshares
ACADACADIA PHARMACEUTICALS INC167,875$4.25Mshares
RAREULTRAGENYX PHARMACEUTICAL IN100,000$3.34Mcall
CUECUE BIOPHARMA INC93,819$2.96Mshares
KPTIKARYOPHARM THERAPEUTICS INC250,300$2.45Mcall
ACRSACLARIS THERAPEUTICS INC400,000$2.12Mshares
AMLXAMYLYX PHARMACEUTICALS INC8,500$153Kcall

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000919574-26-008018 base2026-11-16